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Acute Myocardial Infarction
Coronary Plaque Temperature Measurement Can Identify Culprit Lesions
Plaque rupture leading to vessel occlusion may produce proximal thrombosis,whichmight obscure the locationof the initial area of rupture during angiography.
Takumi and colleagues measured arterial wall temperatures and compared these to
intravascular ultrasound (IVUS) and angiographic images in 45 patients with anterior
acutemyocardial infarction (AMI). In patients with total vessel occlusion, themaximal
temperature (Tmax) site was 8 to 10mmmore distal to the angiographically occlusive
site; for those with reperfusion, themean distance was 1.1mm.When a culprit plaque
could be identified by IVUS, it correlated with the area of highest temperature.
Temperature measurement of the coronary arterial wall can identify the culprit plaque
in AMI and confirms that proximal thrombus may mask the initial culprit lesion.
See page 2197. See figure.
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Acute Myocardial Infarction
Coxsackie Infection May Increase Risk of Fatal MI
Coxsackievirus-B (CV-B) serotypes are known to persistently infect human myo-cytes and vascular endothelial cells, but the pathological significance of this is
unclear. Andréoletti and colleagues assessed myocardial sections obtained at autopsy
from patients dying of acute myocardial infarction (AMI) versus those dying of
noncoronary cardiac disease or of other causes. Positive immunostaining for the capsid
viral protein 1 was present in 40% of patients dying of AMI, which was 15 times
higher than in patients dying from accidental causes and 7 times higher than in
those dying of noncoronary cardiac disease. This study shows for the first time the
presence of an active CV-B infection in a high proportion of patients with AMI.
See page 2207. See figure.
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Cardiac Pharmacology
Tolerance to NTG Linked to Inhibition
of ALDH-2 and Reactive Oxygen Species
Hink and colleagues hypothesized that inhibition of the nitroglycerin bioactivat-ing enzyme mitochondrial aldehyde dehydrogenase (ALDH-2) contributes to
nitroglycerin (NTG) tolerance. They analyzed mammary artery sections and saphe-
nous vein sections harvested during bypass surgery in patients treated with intravenous
NTG for48 h prior to surgery versus those with no NTG exposure. Arteries from
patients treated with NTG showed a lack of vasodilation in response to NTG, which
was mimicked by incubation of nontolerant vessels with an ALDH-2 inhibitor.
Furthermore, patients treated with NTG showed decreased expression and activity of
ALDH-2; ALDH-2 activity could be restored by incubation with a sulfhydryl group
donor, suggesting that reactive oxygen species are the etiology. This study suggests that
NTG use promotes production of reactive oxygen species that decreases ALDH-2
activity, which leads to decreased efficacy of NTG. See page 2226. See figure.
(continued) A-32Heart Rhythm Disorders
Driving Appears to be Safe for Those With ICDs
The safety of driving for patients with a history of ventricular tachycardia (VT) orventricular fibrillation (VF) is unclear. The TOVA (Triggers of Ventricular
Arrhythmia) study compared the risk of implantable cardioverter-defibrillator (ICD)
shock for VT/VF both during and up to 60 min after driving. The absolute risk of
ICD shock for VT/VF within 1 h of driving was estimated to be 1 episode per 25,116
person-hours spent driving, and there was only 1 accident associated with an arrhyth-
mia. The risk of shocks for VT/VF occurred primarily during the 30-min period
following driving (relative risk  4.46) rather than during the driving episode itself
(relative risk  1.05). Although the risk of ICD shock for VT/VF was transiently
increased in the 30-min period after driving, the risk was not elevated during driving
and the absolute risk was low, suggesting that patients with ICDs are safe to drive.
See page 2233.
